Steven Cohen Edgewise Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 106,562 shares of EWTX stock, worth $2.93 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
106,562Holding current value
$2.93 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$414 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$245 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$169 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$166 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$138 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.74B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...